- Home
- BEAM vs SHOO Comparison
BEAM vs SHOO Comparison
Compare BEAM & SHOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAM
- SHOO
- Stock Information
- Founded
- BEAM 2017
- SHOO 1990
- Country
- BEAM United States
- SHOO United States
- Employees
- BEAM N/A
- SHOO N/A
- Industry
- BEAM Biotechnology: Biological Products (No Diagnostic Substances)
- SHOO Shoe Manufacturing
- Sector
- BEAM Health Care
- SHOO Consumer Discretionary
- Exchange
- BEAM Nasdaq
- SHOO Nasdaq
- Market Cap
- BEAM 2.3B
- SHOO 2.8B
- IPO Year
- BEAM 2020
- SHOO 1993
- Fundamental
- Price
- BEAM $19.53
- SHOO $26.64
- Analyst Decision
- BEAM Strong Buy
- SHOO Hold
- Analyst Count
- BEAM 11
- SHOO 6
- Target Price
- BEAM $50.50
- SHOO $40.20
- AVG Volume (30 Days)
- BEAM 2.5M
- SHOO 1.8M
- Earning Date
- BEAM 05-06-2025
- SHOO 04-30-2025
- Dividend Yield
- BEAM N/A
- SHOO 3.16%
- EPS Growth
- BEAM N/A
- SHOO 2.17
- EPS
- BEAM N/A
- SHOO 2.35
- Revenue
- BEAM $63,518,000.00
- SHOO $2,282,927,000.00
- Revenue This Year
- BEAM N/A
- SHOO $20.37
- Revenue Next Year
- BEAM $6.32
- SHOO $8.99
- P/E Ratio
- BEAM N/A
- SHOO $11.30
- Revenue Growth
- BEAM N/A
- SHOO 15.21
- 52 Week Low
- BEAM $18.30
- SHOO $24.56
- 52 Week High
- BEAM $35.25
- SHOO $50.01
- Technical
- Relative Strength Index (RSI)
- BEAM 31.67
- SHOO 34.11
- Support Level
- BEAM $21.60
- SHOO $26.75
- Resistance Level
- BEAM $22.97
- SHOO $27.51
- Average True Range (ATR)
- BEAM 1.70
- SHOO 0.95
- MACD
- BEAM -0.36
- SHOO 0.53
- Stochastic Oscillator
- BEAM 12.07
- SHOO 70.51
Stock Price Comparison Chart: BEAM vs SHOO
About BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.
About SHOO Steven Madden Ltd.
Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its own stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.